TSLL vs TSLA: Daily Leverage, or Just the Shares?

Overview

TSLA is Tesla's stock, trading directly at its market price of $342.27 per share with no distributions. TSLL is a leveraged ETF from Direxion that targets 1.5× daily returns of Tesla's stock price movements, trading at $8.76 and distributing 4.79% annually. The key distinction is structural: one is the underlying company itself; the other is a derivative designed for tactical, short-term upside capture through leverage, not buy-and-hold equity ownership.

How they differ

TSLA is a direct equity stake in Tesla's business—no leverage, no daily rebalancing, no synthetic mechanics. TSLL amplifies Tesla's price moves by 1.5× on a daily basis, meaning it compounds volatility and is designed to reset its hedge daily, not to track Tesla over months or years. TSLA's beta is 1.827; TSLL's is 3.37, reflecting the embedded leverage multiplier and daily decay drag. TSLA pays no dividend and carries a zero explicit expense ratio; TSLL charges 0.96% annually and distributes 4.79%, funded partly by daily rebalancing gains and partly by NAV erosion over time. TSLL has $3.23B in AUM and launched in August 2022, while TSLA is the underlying stock itself, priced by the market. The structural difference means TSLL's performance will lag TSLA's price appreciation over periods longer than one day, especially in choppy or sideways markets.

Who each is best for

TSLA: Investors holding a long-term conviction in Tesla's automotive, energy, and services strategy who can tolerate equity volatility (beta 1.827) and are comfortable receiving no current income from their position. Fits buy-and-hold portfolios where capital appreciation and business fundamentals drive the thesis.

TSLL: Fits traders and tactical allocators seeking to amplify Tesla's daily price moves over short holding periods (days to weeks), who understand that leverage resets daily and that the fund is not designed for multi-month or multi-year holding. Designed for investors comfortable with compounding volatility drag and regular loss-of-value from daily rebalancing in sideways or declining markets.

Key risks to know

• Leverage decay in sideways or declining markets. TSLL rebalances daily to maintain its 1.5× multiplier. In choppy price action, this compounding of daily resets erodes NAV relative to a simple 1.5× buy-and-hold Tesla position, especially if the market moves down or trades in a range.

• Extreme volatility amplification. TSLA already carries a beta of 1.827. TSLL's 3.37 beta means a 10% move in Tesla translates to roughly 15% price movement in the fund, outside of any rebalancing slippage. Drawdowns can be severe and swift.

• Mismatch between fund design and common holding periods. TSLL is built for daily tactical trading. Investors holding it for months or years will likely see NAV erosion relative to owning TSLA outright and applying leverage themselves through a margin loan, because daily rebalancing costs accumulate silently.

• Distribution sustainability and return-of-capital risk. TSLL's 4.79% distribution exceeds typical equity appreciation rates and appears to rely partly on NAV depletion, not just reinvested gains. Over multi-year periods, this is likely to erode the fund's per-share value.

• Single-security concentration and no diversification. Both securities are pure-play Tesla exposure with no portfolio diversification. Any deterioration in Tesla's competitive position, execution, or market sentiment directly and fully cascades to the investment.

Bottom line

TSLA is a direct business stake in Tesla with no distributions and no embedded decay mechanics; suitable for long-term investors comfortable with single-name Tesla risk. TSLL is a leveraged daily-reset product that compounds volatility and suffers silent NAV drag outside of 1–5 day trading windows; it's a tactical tool, not a substitute for owning Tesla. If you want stable long-term ownership of Tesla's business, TSLA aligns with that goal; if you're seeking amplified daily moves as a short-term tactical bet, TSLL's embedded costs and rebalancing mechanics warrant careful scrutiny. Past performance does not predict future results.